{"cik":1778922,"taxonomy":"us-gaap","tag":"OtherAssetsNoncurrent","label":"Other Assets, Noncurrent","description":"Amount of noncurrent assets classified as other.","entityName":"SpyGlass Pharma, Inc.","units":{"USD":[{"end":"2024-12-31","val":453000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2024Q4I"},{"end":"2025-12-31","val":492000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26"},{"end":"2025-12-31","val":492000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14"},{"end":"2025-12-31","val":492000,"accn":"0001778922-26-000045","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-06","frame":"CY2025Q4I"},{"end":"2026-03-31","val":789000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2026Q1I"},{"end":"2026-06-30","val":759000,"accn":"0001778922-26-000045","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-06","frame":"CY2026Q2I"}]}}